Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Qiaoying Hu
Cytomembranic PD-L1 Expression in Locoregionally Advanced Nasopharyngeal Carcinoma
OncoTargets and Therapy
Oncology
Pharmacology
Related publications
Experience With Combination of Nimotuzumab and Intensity-Modulated Radiotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
OncoTargets and Therapy
Oncology
Pharmacology
P3.04-13 PD-L1-Gene Expression by nCounter Correlates With PD-L1 Protein Expression in Advanced Non-Small Cell Lung Cancer (NSCLC)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Prolonged Interval Between Initiation of Neoadjuvant Chemotherapy and Radiotherapy Impairs Long Term Survivals in Locoregionally Advanced Nasopharyngeal Carcinoma
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Genetic Variations in Radiation and Chemotherapy Drug Action Pathways and Survival in Locoregionally Advanced Nasopharyngeal Carcinoma Treated With Chemoradiotherapy
PLoS ONE
Multidisciplinary
Is Pretreatment Epstein-Barr Virus DNA Still Associated With 6-Year Survival Outcomes in Locoregionally Advanced Nasopharyngeal Carcinoma?
Journal of Cancer
Oncology
Significance of PD‑L1 Clones and C‑MET Expression in Hepatocellular Carcinoma
Oncology Letters
Cancer Research
Oncology
Optimal Sequencing of Chemotherapy With Chemoradiotherapy Based on TNM Stage Classification and EBV DNA in Locoregionally Advanced Nasopharyngeal Carcinoma
Cancer Communications
Cancer Research
Oncology
PD‑L1 Expression Is Associated With Advanced Non‑small Cell Lung Cancer
Oncology Letters
Cancer Research
Oncology
Reduction of Target Volume and the Corresponding Dose for the Tumor Regression Field After Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
Cancer Research and Treatment
Cancer Research
Oncology